Full Press Release Details
Trulieve Reports Fourth Quarter and Record Full Year 2022 Results
Exceeding $1.2 Billion in Revenue
Tallahassee, FL March 8, 2023 Trulieve Cannabis Corp.
(CSE: TRUL) (OTCQX: TCNNF) ( Trulieve or the Company ), a leading and top-performing cannabis company in the U.S., today announced its results for the fourth quarter and
full year ended December 31, 2022. Results are reported in U.S. dollars and in accordance with U.S. Generally Accepted Accounting Principles unless otherwise indicated. Numbers may not sum perfectly due to rounding.
Q4 2022 Financial and Operational Highlights*
2022 Full Year Financial
and Operational Highlights*
Management Commentary
Trulieve has grown to surpass $1.2 billion in revenue in less than seven years, a notable milestone and a testament to the agility of our
team, said Kim Rivers, Trulieve CEO. Our success is the culmination of thoughtful intention, superb execution, and best in class capabilities for rapid growth.
Rivers continued, With increasing mainstream support and meaningful regulatory reform on the horizon, tremendous growth opportunities lie ahead for U.S.
legal cannabis. In 2023, we are laser focused on cash generation while investing to build a sustainable company designed to thrive in an integrated commerce environment.
Financial Highlights*
| Results of Operations | For the Three Months Ended | For the Full Year Ended | ||||||||||||||||||||||||||||||
| (Figures in millions and % change based on these figures) | December 31, 2022 | December 31, 2021 | change | September 30, 2022 | change | December 31, 2022 | December 31, 2021 | change | ||||||||||||||||||||||||
| Revenue | $ | 302 | $ | 305 | -1 | % | $ | 301 | 0 | % | $ | 1,240 | $ | 938 | 32 | % | ||||||||||||||||
| Gross Profit | $ | 150 | $ | 134 | 12 | % | $ | 168 | -11 | % | $ | 682 | $ | 568 | 20 | % | ||||||||||||||||
| Gross Margin % | 50 | % | 44 | % | 56 | % | 55 | % | 61 | % | ||||||||||||||||||||||
| Adjusted Gross Profit | $ | 162 | $ | 181 | -10 | % | $ | 172 | -6 | % | $ | 703 | $ | 621 | 13 | % | ||||||||||||||||
| Adjusted Gross Margin % | 54 | % | 59 | % | 57 | % | 57 | % | 66 | % | ||||||||||||||||||||||
| Operating Expenses | $ | 156 | $ | 150 | 4 | % | $ | 198 | -21 | % | $ | 650 | $ | 368 | 77 | % | ||||||||||||||||
| Operating Expenses % | 52 | % | 49 | % | 65 | % | 52 | % | 39 | % | ||||||||||||||||||||||
| Net Income (Loss)** | $ | (77 | ) | $ | (72 | ) | $ | (115 | ) | $ | (246 | ) | $ | 18 | ||||||||||||||||||
| Net Income (Loss) Continuing Ops | $ | (76 | ) | $ | (70 | ) | $ | (77 | ) | $ | (205 | ) | $ | 19 | ||||||||||||||||||
| Adjusted Net Income (Loss) | $ | (35 | ) | $ | 2 | $ | 4 | $ | (30 | ) | $ | 123 | ||||||||||||||||||||
| Diluted Shares Outstanding | 189 | 145 | 189 | 188 | 147 | |||||||||||||||||||||||||||
| EPS Continuing Ops | $ | (0.40 | ) | $ | (0.48 | ) | $ | (0.41 | ) | $ | (1.06 | ) | $ | 0.14 | ||||||||||||||||||
| Adjusted EPS | $ | (0.18 | ) | $ | 0.01 | $ | 0.02 | $ | (0.16 | ) | $ | 0.84 | ||||||||||||||||||||
| Adjusted EBITDA | $ | 85 | $ | 101 | -16 | % | $ | 99 | -14 | % | $ | 400 | $ | 385 | 4 | % | ||||||||||||||||
| Adjusted EBITDA Margin % | 28 | % | 33 | % | 33 | % | 32 | % | 41 | % |
The Company will host a conference call
and live audio webcast on March 8, 2023, at 8:30 A.M. Eastern time, to discuss its fourth quarter and full year 2022 financial results. Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes
| North American toll free: 1-888-317-6003 | Passcode: 0344386 | |
| International: 1-412-317-6061 | Passcode: 0344386 |
A live audio webcast of the conference call will be available at:
presentation and archived replay of the webcast will be available at:
The Company s Form 10-K for the year ended December 31, 2022, will be available on the SEC s website or
at https://investors.trulieve.com/annual-reports-and-proxy. The Company s Management Discussion and Analysis for the period and the accompanying financial
statements and notes will be available under the Company s profile on SEDAR and on its website at https://investors.trulieve.com/quarterly-results. This news release is not in any way a substitute for reading those financial statements,
including the notes to the financial statements.
Trulieve Cannabis Corp.
Consolidated Balance Sheets
| 2022 | 2021 | |||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 212.3 | $ | 230.1 | ||||
| Restricted cash | 6.6 | 3.0 | ||||||
| Accounts receivable, net | 9.4 | 8.6 | ||||||
| Inventories, net | 297.8 | 209.9 | ||||||
| Prepaid expenses and other current assets | 63.6 | 68.1 | ||||||
| Notes receivable - current portion | 0.7 | 1.5 | ||||||
| Assets associated with discontinued operations | 2.5 | 3.6 | ||||||
| Total current assets | 593.0 | 524.9 | ||||||
| Property and equipment, net | 796.9 | 779.4 | ||||||
| Right of use assets - operating, net | 101.4 | 111.7 | ||||||
| Right of use assets - finance, net | 76.2 | 66.8 | ||||||
| Intangible assets, net | 1,012.6 | 1,081.2 | ||||||
| Goodwill | 791.5 | 765.4 | ||||||
| Notes receivable, net | 12.0 | 12.1 | ||||||
| Other assets | 14.7 | 17.6 | ||||||
| Long-term assets associated with discontinued operations | 0.7 | 52.2 | ||||||
| TOTAL ASSETS | $ | 3,399.0 | $ | 3,411.4 | ||||
| LIABILITIES | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable and accrued liabilities | $ | 83.2 | $ | 93.8 | ||||
| Income tax payable | 49.0 | 28.1 | ||||||
| Deferred revenue | 9.5 | 7.2 | ||||||
| Notes payable - current portion, net | 12.5 | 10.1 | ||||||
| Operating lease liabilities - current portion | 10.4 | 10.0 | ||||||
| Finance lease liabilities - current portion | 8.7 | 6.2 | ||||||
| Construction finance liabilities - current portion | 1.2 | 0.9 | ||||||
| Contingencies | 34.7 | 13.0 | ||||||
| Liabilities associated with discontinued operations | 0.5 | 0.1 | ||||||
| Total current liabilities | 209.7 | 169.4 | ||||||
| Long-Term Liabilities: | ||||||||
| Notes payable, net | 94.2 | 6.5 | ||||||
| Private placement notes, net | 541.7 | 462.9 | ||||||
| Warrant liabilities | 0.3 | 2.9 | ||||||
| Operating lease liabilities | 102.4 | 107.6 | ||||||
| Finance lease liabilities | 75.8 | 65.2 | ||||||
| Construction finance liabilities | 182.4 | 175.2 | ||||||
| Deferred tax liabilities | 224.1 | 241.9 | ||||||
| Other long-term liabilities | 26.2 | 8.4 | ||||||
| Long-term liabilities associated with discontinued operations | 14.6 | 24.0 | ||||||
| TOTAL LIABILITIES | 1,471.3 | 1,264.0 | ||||||
| Commitments and contingencies | ||||||||
| SHAREHOLDERS EQUITY | ||||||||
| Common Stock, no par value; unlimited shares authorized. 185,987,512 and 180,504,172 issued and outstanding as of December 31, 2022 and December 31, 2021, respectively. | ||||||||
| Additional paid-in-capital | 2,045.0 | 2,008.1 | ||||||
| Accumulated (deficit) earnings | (113.8 | ) | 137.7 | |||||
| Non-controlling interest | (3.5 | ) | 1.6 | |||||
| TOTAL SHAREHOLDERS EQUITY | 1,927.7 | 2,147.4 | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $ | 3,399.0 | $ | 3,411.4 |
Trulieve Cannabis Corp.
Consolidated Statements of Operations and Comprehensive (Loss) Income
(in millions, except per share data)
| Three Months Ended | Full Year Ended | |||||||||||||||
| December 31, 2022 | December 31, 2021 | December 31, 2022 | December 31, 2021 | |||||||||||||
| Revenues, net of discounts | $ | 302.2 | $ | 304.9 | $ | 1,239.8 | $ | 938.0 | ||||||||
| Cost of goods sold | 152.5 | 170.8 | 557.8 | 370.2 | ||||||||||||
| Gross profit | 149.7 | 134.1 | 682.0 | 567.8 | ||||||||||||
| Expenses: | ||||||||||||||||
| Sales and marketing | 60.9 | 72.3 | 284.9 | 215.1 | ||||||||||||
| General and administrative | 64.9 | 44.6 | 169.7 | 100.5 | ||||||||||||
| Depreciation and amortization | 30.7 | 27.4 | 119.4 | 47.2 | ||||||||||||
| Impairment and disposal of long-lived assets, net | (0.6 | ) | 5.4 | 75.5 | 5.4 | |||||||||||
| Total expenses | 155.9 | 149.7 | 649.6 | 368.3 | ||||||||||||
| (Loss) Income from operations | (6.3 | ) | (15.6 | ) | 32.4 | 199.6 | ||||||||||
| Other income (expense): | ||||||||||||||||
| Interest expense | (23.0 | ) | (14.1 | ) | (79.8 | ) | (34.8 | ) | ||||||||
| Change in fair value of derivative liabilities - warrants | 0.0 | 0.2 | 2.6 | 0.2 | ||||||||||||
| Other income (expense), net | (1.6 | ) | 0.7 | 1.4 | 1.1 | |||||||||||
| Total other expense, net | (24.6 | ) | (13.2 | ) | (75.8 | ) | (33.5 | ) | ||||||||
| (Loss) Income before provision for income taxes | (30.8 | ) | (28.7 | ) | (43.3 | ) | 166.1 | |||||||||
| Provision for income taxes | 45.1 | 41.4 | 161.8 | 146.7 | ||||||||||||
| Net (loss) income from continuing operations and comprehensive (loss) income | (75.9 | ) | (70.2 | ) | (205.2 | ) | 19.4 | |||||||||
| Net loss from discontinued operations, net of tax benefit of ($3,776), $642, $10,663, and $642, respectively | (5.2 | ) | (1.9 | ) | (47.6 | ) | (1.9 | ) | ||||||||
| Net (loss) income | (81.2 | ) | (72.1 | ) | (252.7 | ) | 17.4 | |||||||||
| Less: Net loss and comprehensive loss attributable to non-controlling interest from continuing operations | (4.1 | ) | (0.6 | ) | (6.7 | ) | (0.6 | ) | ||||||||
| Net (loss) income and comprehensive (loss) income attributable to common shareholders | $ | (77.0 | ) | $ | (71.5 | ) | $ | (246.1 | ) | $ | 18.0 | |||||
| Net (loss) income per share - Continuing operations: | ||||||||||||||||
| Basic and diluted | $ | (0.40 | ) | $ | (0.48 | ) | $ | (1.06 | ) | $ | 0.14 | |||||
| Net loss per share - Discontinued operations: | ||||||||||||||||
| Basic and diluted | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.25 | ) | $ | (0.01 | ) | ||||
| Weighted average number of common shares used in computing net (loss) income per share: | ||||||||||||||||
| Basic | 188.8 | 145.1 | 188.0 | 139.4 | ||||||||||||
| Diluted | 188.8 | 145.1 | 188.0 | 146.8 |
Non-GAAP Financial Measures
In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial
measures, including adjusted EBITDA, adjusted gross profit, adjusted net income (loss), adjusted net income (loss) per diluted share. Our management uses these non-GAAP financial measures in conjunction with
GAAP financial measures to evaluate our operating results and financial performance. We believe these measures are useful to investors as they are widely used measures of performance and can facilitate comparison to other companies. These non-GAAP financial measures are not, and should not be considered as, measures of liquidity. These non-GAAP financial measures have limitations as analytical tools in that
they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Because of these limitations, these non-GAAP financial measures should be considered
along with GAAP financial performance measures. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information
prepared and presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures. A
reconciliation of the non-GAAP financial measures to such GAAP measures can be found below. These non-GAAP financial measures should be considered supplemental to, and
not a substitute for, our reported financial results prepared in accordance with GAAP.
Non-GAAP Adjusted EBITDA
The following table presents a reconciliation of GAAP net income (loss) to non-GAAP Adjusted EBITDA, for each of the periods presented:
| For the Three Months Ended | For the Full Year Ended | |||||||||||||||||||
| (Amounts expressed in millions of United States dollars) | December 31, 2022 | December 31, 2021 | September 30, 2022 | December 31, 2022 | December 31, 2021 | |||||||||||||||
| Net Income (Loss) GAAP | $ | (77.0 | ) | $ | (71.5 | ) | $ | (114.6 | ) | $ | (246.1 | ) | $ | 18.0 | ||||||
| Add (Deduct) Impact of: | ||||||||||||||||||||
| Interest Expense, net | $ | 23.0 | $ | 14.1 | $ | 19.3 | $ | 79.8 | $ | 34.8 | ||||||||||
| Provision For Income Taxes | $ | 45.1 | $ | 41.4 | $ | 28.2 | $ | 161.8 | $ | 146.7 | ||||||||||
| Depreciation and Amortization | $ | 30.7 | $ | 27.4 | $ | 30.2 | $ | 119.4 | $ | 47.2 | ||||||||||
| Depreciation in COGS | $ | 13.4 | $ | 9.7 | $ | 14.6 | $ | 52.5 | $ | 24.1 | ||||||||||
| EBITDA | $ | 35.2 | $ | 21.1 | $ | (22.3 | ) | $ | 167.4 | $ | 270.8 | |||||||||
| Impairment and Disposal of Long-lived Assets, net | $ | (0.6 | ) | $ | 5.4 | $ | 54.6 | $ | 75.5 | $ | 5.4 | |||||||||
| Results of Discontinued Operations | $ | 5.2 | $ | 1.9 | $ | 38.1 | $ | 47.6 | $ | 1.9 | ||||||||||
| Acquisition and Transaction Costs | $ | 7.5 | $ | 1.5 | $ | 7.0 | $ | 24.8 | $ | 15.8 | ||||||||||
| Integration and Transition Costs | $ | 4.0 | $ | 22.9 | $ | 6.7 | $ | 21.1 | $ | 25.6 | ||||||||||
| Other Non-Recurring Costs | $ | 16.3 | $ | 3.4 | $ | 1.9 | $ | 27.8 | $ | 5.1 | ||||||||||
| Share-Based Compensation and Related Premiums | $ | 3.6 | $ | 7.0 | $ | 4.3 | $ | 18.1 | $ | 13.4 | ||||||||||
| Legislative Campaign Contributions | $ | 10.0 | $ | 0.0 | $ | 10.0 | $ | 20.0 | $ | 0.0 | ||||||||||
| Inventory Step Up Fair Value | $ | 0.0 | $ | 38.0 | $ | 0.0 | $ | 1.0 | $ | 41.2 | ||||||||||
| Covid Related Expenses | $ | 0.0 | $ | 0.2 | $ | 0.2 | $ | 0.8 | $ | 6.2 | ||||||||||
| Other Expense (Income), net | $ | 1.6 | $ | (0.7 | ) | $ | (0.4 | ) | $ | (1.4 | ) | $ | (1.1 | ) | ||||||
| Fair Value of Derivative Liabilities - Warrants | $ | (0.0 | ) | $ | (0.2 | ) | $ | (0.4 | ) | $ | (2.6 | ) | $ | (0.2 | ) | |||||
| Results of Entities Not Legally Controlled | $ | 1.9 | $ | 0.5 | $ | (0.9 | ) | $ | (0.0 | ) | $ | 0.5 | ||||||||
| Adjusted EBITDA Non-GAAP | $ | 84.7 | $ | 100.9 | $ | 98.8 | $ | 400.1 | $ | 384.6 |
Reconciliation of Non-GAAP Adjusted Gross Profit
The following table presents a reconciliation of GAAP gross profit to non-GAAP adjusted gross profit, for each of the
| For the Three Months Ended | For the Full Year Ended | |||||||||||||||||||
| (Amounts expressed in millions of United States dollars) | December 31, 2022 | December 31, 2021 | September 30, 2022 | December 31, 2022 | December 31, 2021 | |||||||||||||||
| Gross Profit GAAP | $ | 149.7 | $ | 134.1 | $ | 168.0 | $ | 682.0 | $ | 567.8 | ||||||||||
| Gross Margin % GAAP | 50 | % | 44 | % | 56 | % | 55 | % | 61 | % | ||||||||||
| Add (Deduct) Impact of: | ||||||||||||||||||||
| Inventory Step Up Fair Value | $ | 0.0 | $ | 38.0 | $ | 0.0 | $ | 1.0 | $ | 41.2 | ||||||||||
| Transaction, Acquisition, and Integration Costs | $ | 12.4 | $ | 8.5 | $ | 3.8 | $ | 19.8 | $ | 12.4 | ||||||||||
| Adjusted Gross Profit Non-GAAP | $ | 162.1 | $ | 180.6 | $ | 171.9 | $ | 702.9 | $ | 621.4 | ||||||||||
| Adjusted Gross Margin % Non-GAAP | 54 | % | 59 | % | 57 | % | 57 | % | 66 | % |
Reconciliation of Non-GAAP Adjusted Net Income
The following table presents a reconciliation of GAAP net income (loss) to non-GAAP adjusted net income, for each of
the periods presented:
| For the Three Months Ended | For the Full Year Ended | |||||||||||||||||||
| (Amounts expressed in millions of United States dollars) | December 31, 2022 | December 31, 2021 | September 30, 2022 | December 31, 2022 | December 31, 2021 | |||||||||||||||
| Net Income (Loss) GAAP | $ | (77.0 | ) | $ | (71.5 | ) | $ | (114.6 | ) | $ | (246.1 | ) | $ | 18.0 | ||||||
| Add (Deduct) Impact of: | ||||||||||||||||||||
| Share-Based Compensation Related Premiums | $ | 0.0 | $ | 0.0 | $ | 0.0 | $ | 0.0 | $ | 4.2 | ||||||||||
| Fair Value of Derivative Liabilities - Warrants | $ | (0.0 | ) | $ | (0.2 | ) | $ | (0.4 | ) | $ | (2.6 | ) | $ | (0.2 | ) | |||||
| Inventory Step Up Fair Value | $ | 0.0 | $ | 38.0 | $ | 0.0 | $ | 1.0 | $ | 41.2 | ||||||||||
| Transaction, Acquisition, and Integration Costs | $ | 37.8 | $ | 27.9 | $ | 25.5 | $ | 93.7 | $ | 46.5 | ||||||||||
| Covid Related Expenses | $ | 0.0 | $ | 0.2 | $ | 0.2 | $ | 0.8 | $ | 6.2 | ||||||||||
| Impairment and Disposal of Long-lived Assets, Net | $ | (0.6 | ) | $ | 5.4 | $ | 54.6 | $ | 75.5 | $ | 5.4 | |||||||||
| Results of Discontinued Operations | 5.2 | $ | 1.9 | $ | 38.1 | $ | 47.6 | $ | 1.9 | |||||||||||
| Adjusted Net Income (Loss) Non-GAAP | $ | (34.7 | ) | $ | 1.5 | $ | 3.5 | $ | (30.1 | ) | $ | 123.2 |
Reconciliation of Non-GAAP Adjusted Earnings Per Share
The following table presents a reconciliation of GAAP earnings (loss) per share to non-GAAP adjusted earnings per
share, for each of the periods presented:
| For the Three Months Ended | For the Full Year Ended | |||||||||||||||||||
| (Amounts expressed in millions of United States dollars) | December 31, 2022 | December 31, 2021 | September 30, 2022 | December 31, 2022 | December 31, 2021 | |||||||||||||||
| Earnings (Loss) Per Share GAAP | $ | (0.41 | ) | $ | (0.49 | ) | $ | (0.61 | ) | $ | (1.31 | ) | $ | 0.12 | ||||||
| Add (Deduct) Impact of: | ||||||||||||||||||||
| Share-Based Compensation Related Premiums | $ | 0.00 | $ | 0.00 | $ | 0.00 | $ | 0.00 | $ | 0.03 | ||||||||||
| Fair Value of Derivative Liabilities - Warrants | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.00 | ) | |||||
| Inventory Step Up Fair Value | $ | 0.00 | $ | 0.26 | $ | 0.00 | $ | 0.01 | $ | 0.28 | ||||||||||
| Transaction, Acquisition, and Integration Costs | $ | 0.20 | $ | 0.19 | $ | 0.14 | $ | 0.50 | $ | 0.32 | ||||||||||
| Covid Related Expenses | $ | 0.00 | $ | 0.00 | $ | 0.00 | $ | 0.00 | $ | 0.04 | ||||||||||
| Impairment and Disposal of Long-lived Assets, Net | $ | (0.00 | ) | $ | 0.04 | $ | 0.29 | $ | 0.40 | $ | 0.04 | |||||||||
| Results of Discontinued Operations | $ | 0.03 | $ | 0.01 | $ | 0.20 | $ | 0.25 | $ | 0.01 | ||||||||||
| Adjusted Earnings Per Share Non-GAAP | $ | (0.18 | ) | $ | 0.01 | $ | 0.02 | $ | (0.16 | ) | $ | 0.84 |
Forward-Looking Statements
This news release includes forward-looking information and statements within the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements relate to the Company s expectations or forecasts of business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs and include statements regarding cannabis
regulatory reform, the Company s growth opportunities and the Company s investment plans for sustainable growth. Words such as expects , continue , will , anticipates and intends or
similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company s current projections and expectations about future events and financial trends that management believes
might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and
expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause
actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without
limitation, the risks discussed under the heading Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2022 and in our periodic reports subsequently filed with the
United Sates Securities and Exchange Commission and in the Company s filings on SEDAR at www.sedar.com. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of
assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to
rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except
as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from
those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the
Northeast, Southeast, and Southwest, anchored by leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and
existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without
limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.
Instagram: @Trulieve
Christine Hersey, Vice President of Investor Relations
Rob Kremer, Executive Director of
Corporate Communications